KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Haleon 111.53 Bn 109.67 Bn - -
2 Teva Pharmaceutical Industries 39.57 Bn 35.83 Bn 1.97 Bn 8.16%
3 Zoetis 33.84 Bn 31.90 Bn 1.62 Bn 26.15%
4 United Therapeutics 24.62 Bn 22.47 Bn 648.10 Mn 75.05%
5 Aurora Cannabis 17.89 Bn 17.81 Bn 33.43 Mn -
6 Neurocrine Biosciences 15.75 Bn 14.43 Bn 800.70 Mn -129.09%
7 Regencell Bioscience Holdings 13.55 Bn 13.55 Bn - -
8 Elanco Animal Health 10.61 Bn 10.18 Bn 785.00 Mn -2.94%
9 HUTCHMED (China) 10.36 Bn 9.02 Bn - -
10 Alkermes 6.14 Bn 5.63 Bn -116.06 Mn -212.48%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.16%
Dec 31, 2025 -0.60%
Sep 30, 2025 -2.80%
Jun 30, 2025 9.65%
Mar 31, 2025 7.68%
Dec 31, 2024 -6.36%
Sep 30, 2024 -2.37%
Jun 30, 2024 -28.21%
Mar 31, 2024 -34.31%
Dec 31, 2023 28.76%
Sep 30, 2023 5.43%
Jun 30, 2023 -1.19%
Mar 31, 2023 -10.44%
Dec 31, 2022 -26.90%
Sep 30, 2022 -13.10%
Jun 30, 2022 -25.28%
Mar 31, 2022 -16.04%
Dec 31, 2021 49.25%
Sep 30, 2021 -6.02%
Jun 30, 2021 5.81%
Mar 31, 2021 -21.22%
Dec 31, 2020 -58.06%
Sep 30, 2020 14.72%
Jun 30, 2020 78.00%
Mar 31, 2020 -45.02%
Dec 31, 2019 36.43%
Sep 30, 2019 26.14%
Jun 30, 2019 57.50%
Mar 31, 2019 28.31%
Dec 31, 2018 31.09%
Sep 30, 2018 65.72%
Jun 30, 2018 27.70%
Mar 31, 2018 88.93%
Dec 31, 2017 95.83%
Sep 30, 2017 30.00%
Jun 30, 2017 22.81%
Mar 31, 2017 80.77%
Dec 31, 2016 -36.12%
Sep 30, 2016 -376.26%
Jun 30, 2016 5.43%
Mar 31, 2016 -108.67%
Dec 31, 2015 10.52%
Sep 30, 2015 18.26%
Jun 30, 2015 -159.31%
Mar 31, 2015 -4.12%
Dec 31, 2014 60.17%
Sep 30, 2014 23.81%
Jun 30, 2014 7.98%
Mar 31, 2014 16.89%
Dec 31, 2013 -13.52%
Sep 30, 2013 61.15%
Jun 30, 2013 -50.48%
Mar 31, 2013 6.75%
Dec 31, 2012 -15.86%
Sep 30, 2012 9.51%
Jun 30, 2012 -17.24%
Mar 31, 2012 -10.96%